Biomet said it’s completed the first U.S. implantation in an investigational device exemption trial of its Comprehensive Nano stemless shoulder device.

The stemless shoulder, which is already on the market in Europe, is based on Biomet’s T.E.S.S. stemless shoulder, which has been on the market since 2004.

The 1st Comprehensive Nano procedure was performed by Dr. Stephen Brockmeier of the University of Virginia Medical Center in Charlottesville.

"We are excited to be a part of the clinical trial evaluating this potentially significant evolution in shoulder arthroplasty. I was impressed with the initial fixation of the stemless implant and was able to perform the shoulder replacement with minimal bone removal and components aligned with the patient’s natural anatomy," Brockmeier said in prepared remarks.